State MS
Clinical Trials in Mississippi
Recruiting clinical trials with at least one study location in Mississippi. Data updated daily from ClinicalTrials.gov.
Top Conditions in Mississippi
Chronic Lymphocytic Leukemia (2)Small Lymphocytic Lymphoma (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Hypertension (2)Non-small Cell Lung Cancer (1)Opioid Use Disorder (1)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Head and Neck Squamous Cell Carcinoma (1)Hypopharyngeal Squamous Cell Carcinoma (1)Laryngeal Squamous Cell Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Mississippi
How many clinical trials are currently recruiting in Mississippi?
ClinicalMetric currently tracks 58 actively recruiting clinical trials with at least one location in Mississippi. The total number of registered studies—including active but not currently enrolling trials—is 58. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Mississippi?
Mississippi hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Mississippi serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Mississippi?
To join a clinical trial in Mississippi, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Mississippi maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Mississippi
NCT06739122 Phase 3
Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants W...
Condition
Type 2 Diabetes
Enrollment
55 pts
Location
United States, Argentina, Mexico
Sponsor
Eli Lilly and Company
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,600 pts
Location
United States, Austria, France
Sponsor
Bristol-Myers Squibb
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT02616302 Phase 2
Recruiting
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptom...
Condition
Gastroesophageal Reflux Disease (GERD)
Enrollment
70 pts
Location
United States, Canada, Colombia
Sponsor
Takeda
NCT06598319 N/A
Recruiting
Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhi...
Condition
Chronic Rhinitis
Enrollment
30 pts
Location
United States
Sponsor
Aventix Medical Inc.
NCT07540312 N/A
Recruiting
A Prospective Trial of a Variable Compression System for Moderate to Severe Irri...
Condition
IBS (Irritable Bowel Syndrome)
Enrollment
20 pts
Location
United States
Sponsor
PGP Health
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
NCT06588855 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Ulcerative Colitis
Enrollment
350 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06511479 N/A
Recruiting
Jackson Heart Study Women's Hypertension Study
Condition
Hypertension
Enrollment
300 pts
Location
United States
Sponsor
NYU Langone Health
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT05156398 Phase 3
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai...
Condition
Migraine
Enrollment
640 pts
Location
United States, Canada, France
Sponsor
Pfizer
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT05615844 Phase 3
Recruiting
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
Condition
Open tíbia Fracture
Enrollment
312 pts
Location
United States, Canada
Sponsor
University of Maryland, Baltim
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
762 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06029439 Phase 3
Recruiting
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Condition
Major Depressive Disorder
Enrollment
1,000 pts
Location
United States, Brazil, Bulgaria
Sponsor
Neumora Therapeutics, Inc.
NCT05261139 Phase 3
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatr...
Condition
COVID-19
Enrollment
160 pts
Location
United States, Bulgaria, Japan
Sponsor
Pfizer
NCT06470243 Phase 3
Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemothe...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
528 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT06832618 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and A...
Condition
Atopic Dermatitis
Enrollment
240 pts
Location
United States, Belgium, Canada
Sponsor
Incyte Corporation
NCT05407636 Phase 3
Recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Condition
AMD
Enrollment
714 pts
Location
United States, Canada, France
Sponsor
AbbVie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology